Question 1

What is the catalog number for COL6A1, NT (Collagen alpha-1 (VI) Chain) (HRP) discontinued?

Accepted Answer

The catalog number for COL6A1, NT (Collagen alpha-1 (VI) Chain) (HRP) discontinued is C7510-61Y-HRP.

Question 2

What sizes are available for COL6A1, NT (Collagen alpha-1 (VI) Chain) (HRP) discontinued?

Accepted Answer

COL6A1, NT (Collagen alpha-1 (VI) Chain) (HRP) discontinued is available in the following size(s): 200 µL.

Question 3

Is COL6A1, NT (Collagen alpha-1 (VI) Chain) (HRP) discontinued in stock?

Accepted Answer

COL6A1, NT (Collagen alpha-1 (VI) Chain) (HRP) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 5

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 6

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

COL6A1, NT (Collagen alpha-1 (VI) Chain) (HRP) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16 (CDH16/1532R), CF647 conjugate, 0.1mg/mL

CD81 / TAPA-1 (1.3.3.22), CF640R conjugate, 0.1mg/mL

Tenascin C (Stromal Marker For Epithelial Malignancy) (TNC/2981R), CF568 conjugate, 0.1mg/mL

CD137L / 4-1BBL / TNFSF9 (CD137L/1547), CF568 conjugate, 0.1mg/mL

Sarcomeric Actinin Alpha 2 / ACTN2 (ACTN2/3295), CF488A conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, 0.1mg/mL